Axonics Modulation Technologies Inc. (AXNX) Physician Survey Implies Faster Growth Than Modeled - Morgan Stanley
Tweet Send to a Friend
Morgan Stanley analyst David Lewis reiterated an Overweight rating and $53.00 price target on Axonics Modulation Technologies Inc. (NASDAQ: AXNX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
